Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) Change in Acquisitions & Divestments (2011)

Quest Diagnostics' (DGX) quarterly Change in Acquisitions & Divestments came in at $459000.0 in Q4 2011.

Analysis

Quest Diagnostics (DGX) Change in Acquisitions & Divestments (2011) Analysis & Trends

Quest Diagnostics has disclosed Change in Acquisitions & Divestments across 1 years of filings, most recently posting $459000.0 for Q4 2011.

  • In Q4 2011, Change in Acquisitions & Divestments changed N/A year-over-year to $459000.0; the TTM figure through Dec 2012 stood at $459000.0 (changed 0.0% YoY), while the FY2011 annual figure was $214.0 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments came in at $459000.0 for Q4 2011 at Quest Diagnostics.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $459000.0 in Q4 2011 to a low of $459000.0 in Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 459,000.00